KCNH1 and osteosarcoma: To explore the molecular mechanism underlying the oncogenic role of Eag in osteosarcoma, we focused on MAPK pathway because Eag was shown to have a role in the activation of MAPK pathway which is frequently activated in a variety of tumors.